North Immunology Reverse Merger Comes With $180M for Next-Gen Inflammation Drug

North Immunology is going public in a reverse merger with Aethlon Medical. With eczema as the lead indication, the inflammation and immunology biotech aims to show its bispecific antibody offers efficacy and tolerability advantages over Sanofi’s immune disorder juggernaut, Dupixent. The post North Immunology Reverse Merger Comes With $180M for Next-Gen Inflammation Drug appeared first…

Read More

3 Common Drugs Older Adults Might Be Overusing

The scenario often unfolds like this: Medical researchers investigate a frequently used drug and report that it’s less effective for older patients than previously thought, or that its risks outweigh its benefits in older adults. More studies follow, confirming those findings. After a few years, medical associations revise their guidelines, warning that the drug in…

Read More

California Eyes Prison Heat Protections That Fall Short of Workplace Standards

As Californians have weathered relentless heat waves, state workplace safety regulators have repeatedly reminded employers to protect employees from heat illness by providing water, shade, cooldown areas, and additional rest breaks when temperatures climb. But there’s a notable exception in the state’s heat safety rules: Not covered are the nurses, guards, staff, and tens of…

Read More

Gozio – Patient Navigation & Directions!

I had a great conversation and demo with Katie Logan and Christine Smith from Gozio a while back. Finally got it up on THCB. Gozio provides two types of patient navigation for health systems. One as a digital front door helping patients navigate to doctors, services and tools like virtual care and appointments from the…

Read More

Start Counting Your Days

By KIM BELLARD Probably the last thing the world needs is to hear from me about AI’s existential threat, but, really, what else is there to talk about right now? For anyone who has not been following the current furor, the straw that broke the proverbial camel’s back came last week when Jacob Coxon, a…

Read More